Ly9 (SLAMF3) receptor differentially regulates iNKT cell development and activation in mice

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-4141|48|1|99-105

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.48, Iss.1, 2018-01, pp. : 99-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A polymorphism in a phosphotyrosine signalling motif of CD229 (Ly9, SLAMF3) alters SH2 domain binding and T‐cell activation

By  

IMMUNOLOGY, Vol. 146, Iss. 3, 2015-11 ,pp. : 392-400

John Wiley & Sons Inc

Access to resources Recommend Favorite

iNKT cell activation plus T‐cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 18, Iss. 2, 2018-02 ,pp. : 328-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gal‐3 regulates the capacity of dendritic cells to promote NKT‐cell‐induced liver injury

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 2, 2015-02 ,pp. : 531-543

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ligation of Toll-Like Receptor 3 Differentially Regulates M2 and M3 Muscarinic Receptor Expression and Function in Human Airway Smooth Muscle Cells

By  

International Archives of Allergy and Immunology, Vol. 145, Iss. 2, 2007-09 ,pp. : 163-174

Karger

Access to resources Recommend Favorite

Toll‐like receptor 9 and interferon‐γ receptor signaling suppress the B‐cell fate of uncommitted progenitors in mice

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 5, 2015-05 ,pp. : 1313-1325

John Wiley & Sons Inc

Access to resources Recommend Favorite